Клинические рекомендации / Российские+рекомендации+по+ФП+2017

КЛИНИЧЕСКИЕРЕКОМЕНДАЦИИПОПРОВЕДЕНИЮ ЭЛЕКТРОФИЗИОЛОГИЧЕСКИХПРОЦЕДУР УПАЦИЕНТОВСНАРУШЕНИЯМИРИТМАСЕРДЦА

109.Glatter K. A.,ChengJ.,DorostkarP.,etal.(1999)Electrophysiologic effects of adenosine in patients with supraventricular tachycardia. Circulation99:1034–1040.

110.Dougherty A. H.,Jackman W. M.,Naccarelli G. V.,etal.(1992)Acute conversionofparoxysmalsupraventriculartachycardiawithintravenous diltiazem.IV DiltiazemStudyGroup.AmJCardiol70:587–592.

111.Waxman H. L., Myerburg R. J., Appel R., et al. (1981) Verapamil for controlofventricularrateinparoxysmalsupraventriculartachycardia andatrialfibrillationorflutter:adouble-blindrandomizedcross-over study.AnnInternMed94:1–6.

112.Amsterdam E. A., Kulcyski J., Ridgeway M. G. (1991) Efficacy of cardioselective beta-adrenergic blockade with intravenously administered metoprolol in the treatment of supraventricular tachyarrhythmias.JClinPharmacol31:714–718.

113.Das G., Tschida V., Gray R., et al. (1988) Efficacy of esmolol in the treatment and transfer of patients with supraventricular tachyarrhythmias to alternate oral antiarrhythmic agents. J Clin Pharmacol28:746–750.

114.AlboniP.,TomasiC.,MenozziC.,etal.(2001)Efficacyandsafetyofout- of-hospitalself-administeredsingle-doseoraldrugtreatmentinthe managementofinfrequent,well-toleratedparoxysmalsupraventricular tachycardia.JAmCollCardiol37:548–553.

115.Yeh S. J.,Lin F. C.,Chou Y. Y.,etal.(1985)Terminationofparoxysmal supraventriculartachycardiawithasingleoraldoseofdiltiazemand propranolol.Circulation71:104–109.

116.Rinkenberger R. L.,Prystowsky E. N.,Heger J. J.,etal.(1980)Effects ofintravenousandchronicoralverapamiladministrationinpatients withsupraventriculartachyarrhythmias.Circulation62:996–1010.

117.D’Este D., Zoppo F., Bertaglia E., et al. (2007) Long-term outcome of patients with atrioventricular node reentrant tachycardia. Int J Cardiol115:350–353.

118.Langberg J. J., Leon A., Borganelli M., et al. (1993) A randomized, prospective comparison of anterior and posterior approaches to radiofrequency catheter ablation of atrioventricular nodal reentry tachycardia.Circulation87:1551–1556.

119.Kalbfleisch S. J., Strickberger S. A., Williamson B., et al. (1994) Randomized comparison of anatomic and electrogram mapping approachestoablationoftheslowpathwayofatrioventricularnode reentranttachycardia.JAmCollCardiol23:716–723.

421

ГЛАВА3

120.Kay G. N., Epstein A. E., Dailey S. M., et al. (1992) Selective radiofrequency ablation of the slow pathway for the treatment of atrioventricularnodalreentranttachycardia.Evidenceforinvolvement of perinodal myocardium within the reentrant circuit. Circulation 85:1675–1688.

121.Bogun F., Knight B., Weiss R., et al. (1996) Slow pathway ablation in patients with documented but noninducible paroxysmal supraventriculartachycardia.JAmCollCardiol28:1000–1004.

122.O’HaraG.E.,PhilipponF.,ChampagneJ.,etal.(2007)Catheterablation forcardiacarrhythmias:a14-yearexperiencewith5330consecutive patientsattheQuebecHeartInstitute,LavalHospital.CanJCardiol 23(SupplB):67B 70B.

123.Jacobs A. K., Kushner F. G., Ettinger S. M., et al. (2013) ACCF/AHA clinical practice guideline methodology summit report: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 61:213–265.

124.Gambhir D. S.,BhargavaM.,AroraR.,etal.(1995)Electrophysiologic effects and therapeutic efficacy of intravenous flecainide for terminationofparoxysmalsupraventriculartachycardia.IndianHeart J47:237–243.

125.Musto B., Cavallaro C., Musto A., et al. (1992) Flecainide single oral doseformanagementofparoxysmalsupraventriculartachycardiain childrenandyoungadults.AmHeartJ124:110–115.

126.Neumar R. W.,Otto C. W.,Link M. S.,etal.(2010)Part8:adultadvanced cardiovascularlifesupport:2010AmericanHeartAssociationguidelines forcardiopulmonaryresuscitationandemergencycardiovascularcare. Circulation122:S729–S767.

127.Delaney B., Loy J., Kelly A. — ​M. (2011) The relative efficacy of adenosineversusverapamilforthetreatmentofstableparoxysmal supraventriculartachycardiainadults:ameta-analysis.EurJEmerg Med18:148–152.

128.FurlongR.,Gerhardt R. T.,FarberP.,etal.(1995)Intravenousadenosine asfirst-lineprehospitalmanagementofnarrow-complextachycardias byEMSpersonnelwithoutdirectphysiciancontrol.AmJEmergMed 13:383–388.

129.WalfridssonU.,WalfridssonH.(2005)Theimpactofsupraventricular tachycardiasondrivingabilityinpatientsreferredforradiofrequency catheterablation.PacingClinElectrophysiol28:191–195.

422

КЛИНИЧЕСКИЕРЕКОМЕНДАЦИИПОПРОВЕДЕНИЮ ЭЛЕКТРОФИЗИОЛОГИЧЕСКИХПРОЦЕДУР УПАЦИЕНТОВСНАРУШЕНИЯМИРИТМАСЕРДЦА

130.Schatz I.,Ordog G. J.,KarodyR.,etal.(1987)Wolff-Parkinson-White syndromepresentinginatrialfibrillation.AnnEmergMed16:574–578.

131.MittalS.,AyatiS.,Stein K. M.,etal.(2000)Transthoraciccardioversion ofatrialfibrillation:comparisonofrectilinearbiphasicversusdamped sinewavemonophasicshocks.Circulation101:1282–1287.

132.VereckeiA.,DurayG.,SzénásiG.,etal.(2008)Newalgorithmusingonly leadaVRfordifferentialdiagnosisofwideQRScomplextachycardia. HeartRhythm5:89–98.

133.Glatter K. A.,Dorostkar P. C.,YangY.,etal.(2001)Electrophysiological effectsofibutilideinpatientswithaccessorypathways.Circulation 104:1933–1939.

134.Sellers T. D. Jr.., Campbell R. W., Bashore T. M., et al. (1977) Effects ofprocainamideandquinidinesulfateintheWolff-Parkinson-White syndrome.Circulation55:15–22.

135.Huycke E. C.,Sung R. J.,Dias V. C.,etal.(1989)Intravenousdiltiazem forterminationofreentrantsupraventriculartachycardia:aplacebo- controlled,randomized,double-blind, multicenter study.JAmColl Cardiol13:538–544.

136.Hamer A., Peter T., Platt M., et al. (1981) Effects of verapamil on supraventricular tachycardia in patients with overt and concealed Wolff-Parkinson-Whitesyndrome.AmHeartJ101:600–612.

137.Hombach V.,Braun V.,Höpp H. W.,etal.(1981)Antiarrhythmiceffects ofacutebetablockadewithatenololonsupraventriculartachycardias atrestandduringexercise.KlinWochenschr59:123–133.

138.Morady F., DiCarlo L. A. Jr.., Baerman J. M., et al. (1987) Effect of propranololonventricularrateduringatrialfibrillationintheWolff- Parkinson-Whitesyndrome.PacingClinElectrophysiol10:492–496.

139.Sellers T. D. Jr.., Bashore T. M., Gallagher J. J. (1977) Digitalis in the pre-excitationsyndrome.Analysisduringatrialfibrillation.Circulation 56:260–267.

140.Sheinman B. D., Evans T. (1982) Acceleration of ventricular rate by fibrillationassociatedwiththeWolff-Parkinson-Whitesyndrome.Br MedJ(ClinResEd)285:999–1000.

141.BorianiG.,BiffiM.,FrabettiL.,etal.(1996)Ventricularfibrillationafter intravenous amiodarone in Wolff-Parkinson-White syndrome with atrialfibrillation.AmHeartJ131:1214–1216.

142.ShiraishiH.,IshibashiK.,UraoN.,etal.(2002)Twocasesofpolymorphic ventricular tachycardia induced by the administration of verapamil

423

ГЛАВА3

againstparoxysmalsupraventriculartachycardia.InternMed41:445– 448.

143.SchützenbergerW.,LeischF.,GmeinerR.(1987)Enhancedaccessory pathway conduction following intravenous amiodarone in atrial fibrillation.Acasereport.IntJCardiol16:93–95.

144.PapponeC.,VicedominiG.,MangusoF.,etal.(2014)Wolff-Parkinson- Whitesyndromeintheeraofcatheterablation:insightsfromaregistry studyof2169patients.Circulation130:811–819.

145.Jackman W. M.,Wang X. Z.,Friday K. J.,etal.(1991)Catheterablationof accessoryatrioventricularpathways(Wolff-Parkinson-Whitesyndrome) byradiofrequencycurrent.NEnglJMed324:1605–1611.

146.CalkinsH.,LangbergJ.,SousaJ.,etal.(1992)Radiofrequencycatheter ablationofaccessoryatrioventricularconnections in 250 patients. AbbreviatedtherapeuticapproachtoWolff-Parkinson-Whitesyndrome. Circulation85:1337–1346.

147.Dagres N., Clague J. R., Kottkamp H., et al. (1999) Radiofrequency catheter ablation of accessory pathways. Outcome and use of antiarrhythmicdrugsduringfollow-up.EurHeartJ20:1826–1832.

148.SchläpferJ.,FromerM.(2001)Lateclinicaloutcomeaftersuccessful radiofrequencycatheterablationofaccessorypathways.EurHeart J22:605–609.

149.Belhassen B., Rogowski O., Glick A., et al. (2007) Radiofrequency ablationofaccessorypathways:a14yearexperienceattheTelAviv MedicalCenterin508patients.IsrMedAssocJ9:265–270.

150.Kugler J. D., Danford D. A., Deal B. J., et al. (1994) Radiofrequency catheterablationfortachyarrhythmiasinchildrenandadolescents. ThePediatricElectrophysiologySociety.NEnglJMed330:1481–1487.

151.Kugler J. D.,Danford D. A.,HoustonK.,etal.(1997)Radiofrequency catheter ablation for paroxysmal supraventricular tachycardia in childrenandadolescentswithoutstructuralheartdisease.Pediatric EPSociety,RadiofrequencyCatheterAblationRegistry.AmJCardiol 80:1438–1443.

152.SakuraiM.,YasudaH.,KatoN.,etal.(1983)Acuteandchroniceffects ofverapamilinpatientswithparoxysmalsupraventriculartachycardia. AmHeartJ105:619–628.

153.Hopson J. R., Buxton A. E., Rinkenberger R. L., et al. (1996) Safety and utility of flecainide acetate in the routine care of patients with supraventriculartachyarrhythmias:resultsofamulticentertrial.The

424

КЛИНИЧЕСКИЕРЕКОМЕНДАЦИИПОПРОВЕДЕНИЮ ЭЛЕКТРОФИЗИОЛОГИЧЕСКИХПРОЦЕДУР УПАЦИЕНТОВСНАРУШЕНИЯМИРИТМАСЕРДЦА

FlecainideSupraventricularTachycardiaStudyGroup.AmJCardiol 77:72A 82A.

154.Feld G. K.,NademaneeK.,WeissJ.,etal.(1984)Electrophysiologicbasis forthesuppressionbyamiodaroneoforthodromicsupraventricular tachycardiascomplicatingpre-excitationsyndromes.JAmCollCardiol 3:1298–1307.

155.Feld G. K., Nademanee K., Stevenson W., et al. (1988) Clinical and electrophysiologic effects of amiodarone in patients with atrial fibrillation complicating the Wolff-Parkinson-White syndrome. Am HeartJ115:102–107.

156.Bauernfeind R. A., Wyndham C. R., Dhingra R. C., et al. (1980) Serial electrophysiologic testing of multiple drugs in patients with atrioventricularnodalreentrantparoxysmaltachycardia.Circulation 62:1341–1349.

157.Sharma A. D., Yee R., Guiraudon G., et al. (1987) Sensitivity and specificityofinvasiveandnoninvasivetestingforriskofsuddendeath inWolff-Parkinson-Whitesyndrome.JAmCollCardiol10:373–381.

158.GaitaF.,GiustettoC.,RiccardiR.,etal.(1989)Stressandpharmacologic tests as methods to identify patients with Wolff-Parkinson-White syndromeatriskofsuddendeath.AmJCardiol64:487–490.

159.Spar D. S.,Silver E. S.,Hordof A. J.,etal.(2012)Relationoftheutility of exercise testing for risk assessment in pediatric patients with ventricularpreexcitationtopathwaylocation.AmJCardiol109:1011– 1014.

160.WackelP.,IrvingC.,WebberS.,etal.(2012)RiskstratificationinWolff- Parkinson-White syndrome: the correlation between noninvasive andinvasivetestinginpediatricpatients.PacingClinElectrophysiol 35:1451–1457.

161.Klein G. J.,Bashore T. M.,Sellers T. D.,etal.(1979)Ventricularfibrillation intheWolff-Parkinson-Whitesyndrome.NEnglJMed301:1080–1085.

162.Beckman K. J.,Gallastegui J. L.,Bauman J. L.,etal.(1990)Thepredictive valueofelectrophysiologicstudiesinuntreatedpatientswithWolff- Parkinson-Whitesyndrome.JAmCollCardiol15:640–647.

163.Pappone C., Vicedomini G., Manguso F., et al. (2012) Risk of malignantarrhythmiasininitiallysymptomaticpatientswithWolff- Parkinson-White syndrome: results of a prospective long-term electrophysiologicalfollow-upstudy.Circulation125:661–668.

425

ГЛАВА3

164.RinneC.,Klein G. J.,Sharma A. D.,etal.(1987)Relationbetweenclinical presentationandinducedarrhythmiasintheWolff-Parkinson-White syndrome.AmJCardiol60:576–579.

165.Brembilla-Perrot B., Holban I., Houriez P., et al. (2001) Influence of age on the potential risk of sudden death in asymptomatic Wolff- Parkinson-Whitesyndrome.PacingClinElectrophysiol24:1514–1518.

166.PapponeC.,Santinelli V.,MangusoF.,etal.(2003)Arandomizedstudy ofprophylacticcatheterablationinasymptomaticpatientswiththe Wolff-Parkinson-Whitesyndrome.NEnglJMed349:1803–1811.

167.PapponeC.,Santinelli V.,RosanioS.,etal.(2003)Usefulnessofinvasive electrophysiologictestingtostratifytheriskofarrhythmiceventsin asymptomaticpatientswithWolff-Parkinson-Whitepattern:results fromalargeprospectivelong-termfollow-upstudy.JAmCollCardiol 41:239–244.

168.Epstein A. E.,Miles W. M.,Benditt D. G.,etal.(1996)Personalandpublic safetyissuesrelatedtoarrhythmiasthatmayaffectconsciousness: implicationsforregulationandphysicianrecommendations.Amedical/ scientificstatementfromtheAmericanHeartAssociationandthe NorthAmericanSocietyofPacingandElectrophysiology.Circulation 94:1147–1166.

169.Klein G. J.,YeeR.,Sharma A. D.(1989)Longitudinalelectrophysiologic assessmentofasymptomaticpatientswiththeWolff-Parkinson-White electrocardiographicpattern.NEnglJMed320:1229–1233.

170.Leitch J. W., Klein G. J., Yee R., et al. (1990) Prognostic value of electrophysiology testing in asymptomatic patients with Wolff- Parkinson-Whitepattern.Circulation82:1718–1723.

171.MilsteinS.,Sharma A. D.,Klein G. J.(1986)Electrophysiologicprofileof asymptomaticWolff-Parkinson-Whitepattern.AmJCardiol57:1097– 1100.

172.Satoh M., Aizawa Y., Funazaki T., et al. (1989) Electrophysiologic evaluationofasymptomaticpatientswiththeWolff-Parkinson-White pattern.PacingClinElectrophysiol12:413–420.

173.JaïsP.,Shah D. C.,HaïssaguerreM.,etal.(2000)Mappingandablation ofleftatrialflutters.Circulation101:2928–2934.

174.Baker B. M.,Lindsay B. D.,Bromberg B. I.,etal.(1996)Catheterablation ofclinicalintraatrialreentranttachycardiasresultingfromprevious atrial surgery: localizing and transecting the critical isthmus. J Am CollCardiol28:411–417.

426

КЛИНИЧЕСКИЕРЕКОМЕНДАЦИИПОПРОВЕДЕНИЮ ЭЛЕКТРОФИЗИОЛОГИЧЕСКИХПРОЦЕДУР УПАЦИЕНТОВСНАРУШЕНИЯМИРИТМАСЕРДЦА

175.SatomiK.,Chun K. R.J.,TilzR.,etal.(2010)Catheterablationofmultiple unstablemacroreentranttachycardiawithintherightatriumfreewallin patientswithoutpreviouscardiacsurgery.CircArrhythmElectrophysiol 3:24–31.

176.Delacretaz E., Ganz L. I., Soejima K., et al. (2001) Multi atrial maco-re-entry circuits in adults with repaired congenital heart disease: entrainment mapping combined with three-dimensional electroanatomicmapping.JAmCollCardiol37:1665–1676.

177.Magnin-Poull I.,DeChillouC.,MiljoenH.,etal.(2005)Mechanismsof rightatrialtachycardiaoccurringlateaftersurgicalclosureofatrial septaldefects.JCardiovascElectrophysiol16:681–687.

178.Kanagasundram A. N., Baduashvili A., Liu C. F., et al. (2013) A novel criterionfor conductionblock aftercatheterablation ofrightatrial tachycardiaaftermitralvalvesurgery.CircArrhythmElectrophysiol 6:39–47.

179.Teh A. W.,MediC.,LeeG.,etal.(2011)Long-termoutcomefollowing ablationofatrialflutteroccurringlateafteratrialseptaldefectrepair. PacingClinElectrophysiol34:431–435.

180.McElderryH.T.,McGiffinD.C.,Plumb V. J.,etal.(2008)Proarrhythmic aspects of atrial fibrillation surgery: mechanisms of postoperative macroreentranttachycardias.Circulation117:155–162.

181.Wazni O. M.,SalibaW.,FahmyT.,etal.(2006)Atrialarrhythmiasafter surgical maze: findings during catheter ablation. J Am Coll Cardiol 48:1405–1409.

182.CalkinsH.,Kuck K. H.,CappatoR.,etal.(2012)2012HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrialfibrillation:recommendationsforpatientselection,procedural techniques,patientmanagementandfollow-up,definitions,endpoints, andresearchtrialdesign:areportoftheHeartRhythmSociety(HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. DevelopedinpartnershipwiththeEuropeanHeartRhythmAssociation (EHRA), a registered branch of the European Society of Cardiology (ESC) and the European Cardiac Arrhythmia Society (ECAS); and in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), the Asia Pacific Heart Rhythm Society(APHRS),andtheSocietyofThoracicSurgeons(STS).Heart Rhythm9:632–696.e21.

427

ГЛАВА3

183.Blackshear J. L.,Stambler B. S.,Strauss W. E.,etal.(1996)Controlof heartrateduringtransitionfromintravenoustooraldiltiazeminatrial fibrillationorflutter.AmJCardiol78:1246–1250.

184.Singh B. N.,Hecht H. S.,NademaneeK.,etal.(1982)Electrophysiologic and hemodynamic effects of slow-channel blocking drugs. Prog CardiovascDis25:103–132.

185.AkhtarM.,TchouP.,JazayeriM.(1989)Useofcalciumchannelentry blockers in the treatment of cardiac arrhythmias. Circulation 80: IV31–IV39.

186.Delle Karth G., Geppert A., Neunteufl T., et al. (2001) Amiodarone versus diltiazem for rate control in critically ill patients with atrial tachyarrhythmias.CritCareMed29:1149–1153.

187.Ellenbogen K. A., Dias V. C., Plumb V. J., et al. (1991) A placebocontrolledtrialofcontinuousintravenousdiltiazeminfusionfor24hour heart rate control during atrial fibrillation and atrial flutter: a multicenterstudy.JAmCollCardiol18:891–897.

188.Ellenbogen K. A., Dias V. C., Cardello F. P., et al. (1995) Safety and efficacy of intravenous diltiazem in atrial fibrillation or atrial flutter. AmJCardiol75:45–49.

189.Platia E. V.,Michelson E. L.,Porterfield J. K.,etal.(1989)Esmololversus verapamilintheacutetreatmentofatrialfibrillationoratrialflutter. AmJCardiol63:925–929.

190.Salerno D. M.,Dias V. C.,Kleiger R. E.,etal.(1989)Efficacyandsafety ofintravenousdiltiazemfortreatmentofatrialfibrillationandatrial flutter. The Diltiazem-Atrial Fibrillation/Flutter Study Group. Am J Cardiol63:1046–1051.

191.Gallagher M. M.,Guo X. H.,Poloniecki J. D.,etal.(2001)Initialenergy setting,outcomeandefficiencyindirectcurrentcardioversionofatrial fibrillationandflutter.JAmCollCardiol38:1498–1504.

192.Botkin S. B., Dhanekula L. S., Olshansky B. (2003) Outpatient cardioversion of atrial arrhythmias: efficacy, safety, and costs. Am HeartJ145:233–238.

193.PizzaleS.,LemeryR.,Green M. S.,etal.(2009)Frequencyandpredictors oftachycardia-inducedcardiomyopathyinpatientswithpersistent atrialflutter.CanJCardiol25:469–472.

194.Van Gelder I. C., Crijns H. J., Van Gilst W. H., et al. (1991) Prediction ofuneventfulcardioversionandmaintenanceofsinusrhythmfrom direct-currentelectricalcardioversionofchronicatrialfibrillationand flutter.AmJCardiol68:41–46.

428

КЛИНИЧЕСКИЕРЕКОМЕНДАЦИИПОПРОВЕДЕНИЮ ЭЛЕКТРОФИЗИОЛОГИЧЕСКИХПРОЦЕДУР УПАЦИЕНТОВСНАРУШЕНИЯМИРИТМАСЕРДЦА

195.BorianiG.,TukkieR.,Manolis A. S.,etal.(2014)Atrialantitachycardia pacingandmanagedventricularpacinginbradycardiapatientswith paroxysmal or persistent atrial tachyarrhythmias: the MINERVA randomizedmulticentreinternationaltrial.EurHeartJ35:2352–2362.

196.Botkin S. B., Dhanekula L. S., Olshansky B. (2003) Outpatient cardioversion of atrial arrhythmias: efficacy, safety, and costs. Am HeartJ145:233–238.

197.Mitchell A. R.J.,Spurrell P. A.R.,CheatleL.,etal.(2002)Effectofatrial antitachycardiapacingtreatmentsinpatientswithanatrialdefibrillator: randomisedstudycomparingsubthresholdandnominalpacingoutputs. Heart87:433–437.

198.Gillis A. M., Unterberg-Buchwald C., Schmidinger H., et al. (2002) Safety and efficacy of advanced atrial pacing therapies for atrial tachyarrhythmias inpatientswithanew implantable dualchamber cardioverter-defibrillator.JAmCollCardiol40:1653–1659.

199.Waldo A. L.,MacLeanW.A.,Cooper T. B.,etal.(1978)Useoftemporarily placedepicardialatrialwireelectrodesforthediagnosisandtreatment of cardiac arrhythmias following open-heart surgery. J Thorac CardiovascSurg76:500–505.

200.Peters R. W., Shorofsky S. R., Pelini M., et al. (1999) Overdrive atrial pacingforconversionofatrialflutter:comparisonofpostoperative withnonpostoperativepatients.AmHeartJ137:100–103.

201.Ghali W. A.,Wasil B. I.,BrantR.,etal.(2005)Atrialflutterandtherisk ofthromboembolism:asystematicreviewandmeta-analysis.AmJ Med118:101–107.

202.Clemo H. F., Wood M. A., Gilligan D. M., et al. (1998) Intravenous amiodarone for acute heart rate control in the critically ill patient withatrialtachyarrhythmias.AmJCardiol81:594–598.

203.Roberts S. A.,DiazC.,Nolan P. E.,etal.(1993)Effectivenessandcosts of digoxin treatment for atrial fibrillation and flutter. Am J Cardiol 72:567–573.

204.NataleA.,Newby K. H.,PisanóE.,etal.(2000)Prospectiverandomized comparisonofantiarrhythmictherapyversusfirst-lineradiofrequency ablationinpatientswithatrialflutter.JAmCollCardiol35:1898–1904.

205.Bastani H., Drca N., Insulander P., et al. (2013) Cryothermal vs. radiofrequency ablation as atrial flutter therapy: a randomized comparison.Europace15:420–428.

206.Poty H., Saoudi N., Nair M., et al. (1996) Radiofrequency catheter ablation of atrial flutter. Further insights into the various types of

429

ГЛАВА3

isthmusblock:applicationtoablationduringsinusrhythm.Circulation 94:3204–3213.

207.SchwartzmanD.,Callans D. J.,Gottlieb C. D.,etal.(1996)Conduction blockintheinferiorvenacaval-tricuspidvalveisthmus:association withoutcomeofradiofrequencyablationoftypeIatrialflutter.JAm CollCardiol28:1519–1531.

208.Schumacher B., Jung W., Lewalter T., et al. (1999) Radiofrequency ablationofatrialflutterduetoadministrationofclassICantiarrhythmic drugsforatrialfibrillation.AmJCardiol83:710–713.

209.MohantyS.,MohantyP.,DiBiaseL.,etal.(2013)Resultsfromasingleblind,randomizedstudycomparingtheimpactofdifferentablation approaches on long-term procedure outcome in coexistent atrial fibrillationandflutter(APPROVAL).Circulation127:1853–1860.

210.Reithmann C., Hoffmann E., Spitzlberger G., et al. (2000) Catheter ablation of atrial flutter due to amiodarone therapy for paroxysmal atrialfibrillation.EurHeartJ21:565–572.

211.Schumacher B., Jung W., Lewalter T., et al. (1999) Radiofrequency ablationofatrialflutterduetoadministrationofclassICantiarrhythmic drugsforatrialfibrillation.AmJCardiol83:710–713.

212.MohantyS.,MohantyP.,DiBiaseL.,etal.(2013)Resultsfromasingleblind,randomizedstudycomparingtheimpactofdifferentablation approaches on long-term procedure outcome in coexistent atrial fibrillationandflutter(APPROVAL).Circulation127:1853–1860.

213.WazniO.,Marrouche N. F.,Martin D. O.,etal.(2003)Randomizedstudy comparingcombinedpulmonaryvein-leftatrialjunctiondisconnection andcavotricuspidisthmusablationversuspulmonaryvein-leftatrial junctiondisconnectionaloneinpatientspresentingwithtypicalatrial flutterandatrialfibrillation.Circulation108:2479–2483.

214.Coffey J. O.,d’AvilaA.,DukkipatiS.,etal.(2013)Catheterablationof scar-relatedatypicalatrialflutter.Europace15:414–419.

215.Aliot E., Denjoy I. (1996) Comparison of the safety and efficacy of flecainide versus propafenone in hospital out-patients with symptomaticparoxysmalatrialfibrillation/flutter.TheFlecainideAF FrenchStudyGroup.AmJCardiol77:66A 71A.

216.VanGelder I. C.,Crijns H. J.,VanGilst W. H.,etal.(1989)Efficacyand safetyofflecainideacetateinthemaintenanceofsinusrhythmafter electricalcardioversionofchronicatrialfibrillationoratrialflutter.Am JCardiol64:1317–1321.

430